2-((2E,6E)-12-Hydroxy-3,7,11-trimethyldodeca-2,6,10-trien-1-yl)-5,6-dimethoxy-3-methylcyclohexa-2,5-diene-1,4-dione

Catalog No. :
ACFZXL666
CAS No. :
77879-20-0
Molecular Formula :
C24H34O5
Molecular Weight :
402.53

IUPAC Name:2-((2E,6E)-12-hydroxy-3,7,11-trimethyldodeca-2,6,10-trien-1-yl)-5,6-dimethoxy-3-methylcyclohexa-2,5-diene-1,4-dione

2-((2E,6E)-12-Hydroxy-3,7,11-trimethyldodeca-2,6,10-trien-1-yl)-5,6-dimethoxy-3-methylcyclohexa-2,5-diene-1,4-dione structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-((2E,6E)-12-Hydroxy-3,7,11-trimethyldodeca-2,6,10-trien-1-yl)-5,6-dimethoxy-3-methylcyclohexa-2,5-diene-1,4-dione
IUPAC Name2-((2E,6E)-12-hydroxy-3,7,11-trimethyldodeca-2,6,10-trien-1-yl)-5,6-dimethoxy-3-methylcyclohexa-2,5-diene-1,4-dione
Molecular FormulaC24H34O5
Molecular Weight402.53
SMILESCOC1=C(OC)C(=O)C(C/C=C(\C)CC/C=C(\C)CCC=C(C)CO)=C(C)C1=O
InChI KeyZIUZQCKZMWAUSU-FKESNGHESA-N
Synonym2,5-Cyclohexadiene-1,4-dione, 2-(12-hydroxy-3,7,11-trimethyl-2,6,10-dodecatrienyl)-5,6-dimethoxy-3-methyl-, (,E,E)- (9CI)
CAS No.77879-20-0

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACFZXL666 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACFZXL666 route product structure diagram
    ACFZXL66677879-20-0
Inquiry

2. ACFZXL666 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACFZXL666 route product structure diagram
    ACFZXL66677879-20-0
Inquiry

Comments (0)